KAPA logo

Kairos Pharma, Ltd.

KAPA
Healthcare|Biotechnology|US
$0.49
+0.03 (+7.33%)
DCF Value
$1.64
Tangible Book / Share
$1.37
Cash / Share
$0.86

Ownership Breakdown

41.9%
Float
3.4M
Shares Outstanding
1.4M
Float Shares

Major Holders (2)

Combined: 10.0%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
Armistice Capital, LLCIA, OO4.99%884,938Aug 14, 202513D/G
Steven BoydHC, IN4.99%884,938Aug 14, 202513D/G

Insider Trades (23)

Last 4 quarters: 6,700 acquired · 0 disposed
InsiderPositionDateTypeSharesPriceValueFiling
Bhowmick NeilChief Scientific OfficerOct 8, 2025AWARD171,756——Form 4
Bae Hyun W.directorOct 8, 2025AWARD19,084——Form 4
Bae Hyun W.directorSep 16, 2025AWARD10,000——Form 4
Murali RamachandranVP of Research and DevelopmentOct 8, 2025AWARD152,672——Form 4
Keyoung Hansoo MichaeldirectorOct 8, 2025AWARD19,084——Form 4
Keyoung Hansoo MichaeldirectorSep 16, 2025AWARD10,000——Form 4
Singhvi RahuldirectorOct 8, 2025AWARD19,084——Form 4
Samuelson DougChief Financial OfficerOct 8, 2025AWARD152,672——Form 4
Yu John Sdirector, 10 percent owner, officer: CEO and ChairmanOct 8, 2025AWARD190,840——Form 4
Singhvi RahuldirectorDec 10, 2024OTHER0——Form 4
Bhowmick NeilChief Scientific OfficerJan 1, 2025AWARD14,000——Form 4
Murali RamachandranVP of Research and DevelopmentJan 1, 2025AWARD14,000——Form 4
Yu John Sdirector, 10 percent owner, officer: CEO and ChairmanJan 1, 2025AWARD14,000——Form 4
Murali RamachandranVP of Research and DevelopmentNov 25, 2024BUY200$1.59$318.00Form 4
Samuelson DougChief Financial OfficerNov 22, 2024BUY2,500$1.50$3.8KForm 4
Yu John Sdirector, 10 percent owner, officer: CEO and ChairmanNov 20, 2024BUY4,000$1.44$5.8KForm 4
Bhowmick NeilChief Scientific OfficerSep 16, 2024OTHER0——Form 4
MAZANET ROSEMARYdirectorSep 16, 2024OTHER0——Form 4
Murali RamachandranVP of Research and DevelopmentSep 16, 2024OTHER0——Form 4
Keyoung Hansoo MichaeldirectorSep 16, 2024OTHER0——Form 4
Samuelson DougChief Financial OfficerSep 16, 2024OTHER0——Form 4
Yu John Sdirector, 10 percent owner, officer: CEO and ChairmanSep 16, 2024OTHER0——Form 4
Bae Hyun W.directorSep 16, 2024OTHER0——Form 4